Nanox Imaging Ltd. (NASDAQ: NNOX) has entered into a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The announcement, made via a press release, underscores Nanox's ongoing efforts to drive the global transition to preventive health care by making advanced imaging more accessible and affordable.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This deal makes Costa Rica Nanox's third Latin American market this year, following Argentina and Peru, signaling a strategic push into emerging markets where access to advanced medical imaging is often limited.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs of chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions.
This distribution agreement is significant because it represents a tangible step in Nanox's vision to expand the reach of medical imaging both within and beyond traditional hospital settings. By providing a seamless solution from scan to interpretation and beyond, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes. In Costa Rica, where the CCSS is the primary provider of hospital services, the introduction of the Nanox.ARC could help alleviate bottlenecks in imaging access and enable earlier diagnosis, particularly for chronic conditions that benefit from early intervention.
Moreover, the agreement highlights Nanox's commitment to lowering barriers to adoption and improving utilization of medical imaging in regions that are often underserved. The company's integrated approach—combining affordable hardware, AI-driven analytics, cloud infrastructure, clinical expertise, a marketplace, and health information technology—positions it to address the full spectrum of imaging needs. As Nanox continues to expand across Latin America, this deal could serve as a blueprint for future market entries, potentially accelerating the adoption of preventive care globally. For investors, the news signals progress in Nanox's commercialization strategy and its ability to forge partnerships with established distributors like SOLME, which could drive revenue growth and strengthen its market position. The full press release can be viewed at https://ibn.fm/C77lJ.
Nanox's latest updates are available in its newsroom at http://ibn.fm/NNOX. The company remains focused on driving the world's transition to preventive health care through its integrated platform.
